红细胞膜仿生纳米颗粒通过减轻炎症反应在真菌性角膜炎中发挥保护作用
Red Blood Cell Membrane-Camouflaged Biomimetic Nanoparticle Plays a Protective Role in Fungal Keratitis by Reducing the Inflammatory Response
摘要: 目的:探究红细胞膜仿生纳米颗粒在真菌性角膜炎中的保护作用及机制。方法:首先通过角膜荧光素钠染色实验探究红细胞膜仿生纳米颗粒对小鼠角膜的毒性。在体内,用烟曲霉菌孢子感染C57BL/6小鼠角膜,构建烟曲霉菌性角膜炎小鼠模型,用PBS或者红细胞膜仿生纳米颗粒处理,用裂隙灯显微镜拍摄感染后1、3、5天角膜照片并进行临床评分,用RT-PCR检测感染后第3天角膜TNF-α、CCL-2的mRNA表达。在体外,用烟曲霉菌菌丝刺激HCECs后,用红细胞膜仿生纳米颗粒处理,通过RT-PCR检测HCECs中TNF-α、CCL-2的mRNA表达。结果:红细胞膜仿生纳米颗粒对小鼠角膜安全无毒,点眼后角膜未出现荧光素钠染色。较PBS对照组相比,红细胞膜仿生纳米颗粒组小鼠角膜溃疡程度显著减轻,炎症反应水平下降。红细胞膜仿生纳米颗粒降低TNF-α、CCL-2的mRNA表达。结论:红细胞膜仿生纳米颗粒通过减轻炎症反应在烟曲霉菌性角膜炎中发挥保护作用。
Abstract: Objective: To explore the protective effect and mechanism of red blood cell membrane-camouflaged biomimetic nanoparticle on fungal keratitis. Methods: Firstly, the toxicity of red blood cell membrane-camouflaged biomimetic nanoparticle to the cornea of mice was investigated by and corneal fluorescein sodium staining experiment. In vivo, a mouse model of Aspergillus fumigatus keratitis was constructed by infecting the corneas of C57BL/6 mice with Aspergillus fumigatus spores and treated with PBS or red blood cell membrane-camouflaged biomimetic nanoparticle. The photos of the corneas were taken with slit lamp microscope at 1, 3 and 5 days after infection and clinical scores were performed. Meanwhile, PT-PCR was used to detect the mRNA expression of TNF-α and CCL-2 in cornea on day 3 after infection. Then, in vitro, the HCECs were infected with Aspergillus fumigatus and treated with red blood cell membrane-camouflaged biomimetic nanoparticle. And RT-PCR was used to detect the mRNA expression of TNF-α and CCL-2 in HCECs. Results: The red blood cell membrane-camouflaged biomimetic nanoparticle was safe and non-toxic to mouse corneas, and there was no sodium fluorescein staining was observed in corneas after implantation. Compared with PBS control group, the red blood cell membrane-camouflaged biomimetic nanoparticle group significantly reduced the degree of corneal ulcer and the level of inflammation. Meanwhile, the red blood cell membrane-camouflaged biomimetic nanoparticle could decrease the mRNA expression of TNF-α and CCL-2. Conclusion: The red blood cell membrane-camouflaged biomimetic nanoparticle plays a protective role in Aspergillus fumigatus keratitis by reducing inflammatory response.
文章引用:侯亚鑫, 刘星, 林静. 红细胞膜仿生纳米颗粒通过减轻炎症反应在真菌性角膜炎中发挥保护作用[J]. 临床医学进展, 2024, 14(5): 2375-2383. https://doi.org/10.12677/acm.2024.1451696

参考文献

[1] Donovan, C., Arenas, E., Ayyala, R.S., et al. (2022) Fungal Keratitis: Mechanisms of Infection and Management Strategies. Survey of Ophthalmology, 67, 758-769. [Google Scholar] [CrossRef] [PubMed]
[2] Jiang, N., Zhao, G., Lin, J., Hu, L., et al. (2015) Indoleamine 2,3-Dioxygenase Is Involved in the Inflammation Response of Corneal Epithelial Cells to Aspergillus fumigatus Infections. PLOS ONE, 10, e0137423. [Google Scholar] [CrossRef] [PubMed]
[3] Hoffman, J.J., Burton, M.J. and Leck, A. (2021) Mycotic Keratitis—A Global Threat from the Filamentous Fungi. Journal of Fungi, 7, Article 273. [Google Scholar] [CrossRef] [PubMed]
[4] Liu, X., Sui, J., Li, C., et al. (2023) The Preparation and Therapeutic Effects of β-Glucan-Specific Nanobodies and Nanobody-Natamycin Conjugates in Fungal Keratitis. Acta Biomaterialia, 169, 398-409. [Google Scholar] [CrossRef] [PubMed]
[5] Yang, H., Wang, Q., Han, L., et al. (2020) Nerolidol Inhibits the LOX-1/IL-1β Signaling to Protect against the Aspergillus fumigatus Keratitis Inflammation Damage to the Cornea. International Immunopharmacology, 80, Article 106118. [Google Scholar] [CrossRef] [PubMed]
[6] Wang, Y., Yin, M., Gu, L., et al. (2023) The Therapeutic Role and Mechanism of 4-Methoxycinnamic Acid in Fungal Keratitis. International Immunopharmacology, 116, Article 109782. [Google Scholar] [CrossRef] [PubMed]
[7] Austin, A., Lietman, T. and Rose-Nussbaumer, J. (2017) Update on the Management of Infectious Keratitis. Ophthalmology, 124, 1678-1689. [Google Scholar] [CrossRef] [PubMed]
[8] Luan, S., Peng, X., Lin, J., et al. (2022) Gallic Acid Ameliorates Aspergillus fumigatus Keratitis through Reducing Fungal Load and Suppressing the Inflammatory Response. Investigative Ophthalmology & Visual Science, 63, 12. [Google Scholar] [CrossRef] [PubMed]
[9] Lakhani, P., Patil, A. and Majumdar, S. (2019) Challenges in the Polyene-and Azole-Based Pharmacotherapy of Ocular Fungal Infections. Journal of Ocular Pharmacology and Therapeutics, 35, 6-22. [Google Scholar] [CrossRef] [PubMed]
[10] Huang, Y., Gao, X. and Chen, J. (2018) Leukocyte-Derived Biomimetic Nanoparticulate Drug Delivery Systems for Cancer Therapy. Acta Pharmaceutica Sinica B, 8, 4-13. [Google Scholar] [CrossRef] [PubMed]
[11] Ihler, G.M., Glew, R.H. and Schnure, F.W. (1973) Enzyme Loading of Erythrocytes. Proceedings of the National Academy of Sciences, 70, 2663-2666. [Google Scholar] [CrossRef] [PubMed]
[12] Xia, Q., Zhang, Y., Li, Z., et al. (2019) Red Blood Cell Membrane-Camouflaged Nanoparticles: A Novel Drug Delivery System for Antitumor Application. Acta Pharmaceutica Sinica B, 9, 675-689. [Google Scholar] [CrossRef] [PubMed]
[13] Yu, H., Yan, J., Li, Z., et al. (2023) Enhanced Photothermal-Ferroptosis Effects Based on RBCm-Coated PDA Nanoparticles for Effective Cancer Therapy. Journal of Materials Chemistry B, 11, 415-429. [Google Scholar] [CrossRef
[14] McCall, R.L. and Sirianni, R.W. (2013) PLGA Nanoparticles Formed by Single-or Double-Emulsion with Vitamin E-TPGS. Journal of Visualized Experiments, 82, Article 51015. [Google Scholar] [CrossRef] [PubMed]
[15] Alshamsan, A. (2014) Nanoprecipitation Is More Efficient than Emulsion Solvent Evaporation Method to Encapsulate Cucurbitacin I in PLGA Nanoparticles. Saudi Pharmaceutical Journal, 22, 219-222. [Google Scholar] [CrossRef] [PubMed]
[16] Zhang, Z., Qian, H., Yang, M., et al. (2017) Gambogic Acid-Loaded Biomimetic Nanoparticles in Colorectal Cancer Treatment. International Journal of Nanomedicine, 12, 1593-1605. [Google Scholar] [CrossRef
[17] Wu, X., Li, Y., Raza, F., et al. (2021) Red Blood Cell Membrane-Camouflaged Tedizolid Phosphate-Loaded PLGA Nanoparticles for Bacterial-Infection Therapy. Pharmaceutics, 13, Article 99. [Google Scholar] [CrossRef] [PubMed]
[18] Liu, X., You, J., Peng, X., et al. (2020) Mammalian Ste20-Like Kinase 4 Inhibits the Inflammatory Response in Aspergillus fumigatus Keratitis. International Immunopharmacology, 88, Article 107021. [Google Scholar] [CrossRef] [PubMed]
[19] Brown, L., Leck, A.K., Gichangi, M., et al. (2021) The Global Incidence and Diagnosis of Fungal Keratitis. The Lancet Infectious Diseases, 21, E49-E57. [Google Scholar] [CrossRef
[20] Whitcher, J.P., Srinivasan, M. and Upadhyay, M.P. (2001) Corneal Blindness: A Global Perspective. Bulletin of the World Health Organization, 79, 214-221.
[21] Sharma, N., Bagga, B., Singhal, D., et al. (2022) Fungal Keratitis: A Review of Clinical Presentations, Treatment Strategies and Outcomes. The Ocular Surface, 24, 22-30. [Google Scholar] [CrossRef] [PubMed]
[22] Abbondante, S., Leal, S.M., Clark, H.L., et al. (2023) Immunity to Pathogenic Fungi in the Eye. Seminars in Immunology, 67, Article 101753. [Google Scholar] [CrossRef] [PubMed]
[23] Shukla, P.K., Kumar, M. and Keshava, G.B. (2008) Mycotic Keratitis: An Overview of Diagnosis and Therapy. Mycoses, 51, 183-199. [Google Scholar] [CrossRef] [PubMed]
[24] Kimakura, M., Usui, T., Yokoo, S., et al. (2014) Toxicity of Topical Antifungal Agents to Stratified Human Cultivated Corneal Epithelial Sheets. Journal of Ocular Pharmacology and Therapeutics, 30, 810-814. [Google Scholar] [CrossRef] [PubMed]
[25] Niu, Y., Zhao, G., Li, C., et al. (2018) Aspergillus fumigatus Increased PAR-2 Expression and Elevated Proinflammatory Cytokines Expression through the Pathway of PAR-2/ERK1/2 in Cornea. Investigative Ophthalmology & Visual Science, 59, 166-175. [Google Scholar] [CrossRef] [PubMed]
[26] Su, J., Liu, G., Lian, Y., et al. (2018) Preparation and Characterization of Erythrocyte Membrane Cloaked PLGA/ Arsenic Trioxide Nanoparticles and Evaluation of Their in Vitro Anti-Tumor Effect. RSC Advances, 8, 20068-20076. [Google Scholar] [CrossRef
[27] Mills, B., Radhakrishnan, N., Karthikeyan Rajapandian, S.G., et al. (2021) The Role of Fungi in Fungal Keratitis. Experimental Eye Research, 202, Article 108372. [Google Scholar] [CrossRef] [PubMed]
[28] Yang, R.-B., Wu, L.-P., Lu, X.-X., et al. (2021) Immunologic Mechanism of Fungal Keratitis. International Journal of Ophthalmology, 14, 1100-1106. [Google Scholar] [CrossRef] [PubMed]
[29] Espinosa, V., Dutta, O., Mcelrath, C., et al. (2017) Type III Interferon Is a Critical Regulator of Innate Antifungal Immunity. Science Immunology, 2, eaan5357. [Google Scholar] [CrossRef] [PubMed]
[30] Fortingo, N., Melnyk, S., Sutton, S.H., et al. (2022) Innate Immune System Activation, Inflammation and Corneal Wound Healing. International Journal of Molecular Sciences, 23, Article 14933. [Google Scholar] [CrossRef] [PubMed]